Dean KAHN

Person

Boulder, CO, US

People

Patents Grantslast 30 patents

Information Patent Grant
Fused heterocyclic compounds as RET kinase inhibitors
- Patent number 11,964,988
- Issue date Apr 23, 2024
- Array Biopharma Inc.
- James F. Blake
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
KRas G12D inhibitors
- Patent number 11,964,989
- Issue date Apr 23, 2024
- Mirati Therapeutics, Inc.
- Xiaolun Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of BRAF-associated diseases and disorders
- Patent number 11,634,409
- Issue date Apr 25, 2023
- Array Biopharma Inc.
- Patrick Michael Barbour
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibi...
- Patent number 11,472,802
- Issue date Oct 18, 2022
- Array Biopharma Inc.
- Shane M. Walls
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
KRas G12D inhibitors
- Patent number 11,453,683
- Issue date Sep 27, 2022
- Mirati Therapeutics, Inc.
- Xiaolun Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of BRAF-associated diseases and disorders
- Patent number 11,414,404
- Issue date Aug 16, 2022
- Array Biopharma Inc.
- Patrick Michael Barbour
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
KRAS G12D INHIBITORS
- Publication number 20240309020
- Publication date Sep 19, 2024
- Mirati Therapeutics, Inc.
- Xiaolun Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
KRAS G12D INHIBITORS
- Publication number 20230357277
- Publication date Nov 9, 2023
- Mirati Therapeutics, Inc.
- Xiaolun Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KRAS G12D INHIBITORS
- Publication number 20230279025
- Publication date Sep 7, 2023
- Mirati Therapeutics, Inc.
- Xiaolun Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
KRAS G12D INHIBITORS
- Publication number 20230077225
- Publication date Mar 9, 2023
- Mirati Therapeutics, Inc.
- Xiaolun Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF BRAF-ASSOCIATED DISEASES AND DISORDERS
- Publication number 20220288074
- Publication date Sep 15, 2022
- ARRAY BIOPHARMA INC.
- Patrick Michael DOERNER BARBOUR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF BRAF-ASSOCIATED DISEASES AND DISORDERS
- Publication number 20220289721
- Publication date Sep 15, 2022
- ARRAY BIOPHARMA INC.
- Patrick Michael BARBOUR
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS RET KINASE INHIBITORS
- Publication number 20220112214
- Publication date Apr 14, 2022
- ARRAY BIOPHARMA INC.
- James F. BLAKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF BRAF-ASSOCIATED DISEASES AND DISORDERS
- Publication number 20200407344
- Publication date Dec 31, 2020
- ARRAY BIOPHARMA INC.
- Patrick Michael BARBOUR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PYRAZOLYL[4,3-C]PYRIDINE COMPOUNDS AS RET KINASE INHIBI...
- Publication number 20200339579
- Publication date Oct 29, 2020
- ARRAY BIOPHARMA INC.
- Shane M. WALLS
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Fused heterocyclic compounds as RET kinase inhibitors

KRas G12D inhibitors

Compounds for the treatment of BRAF-associated diseases and disorders

Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibi...

KRas G12D inhibitors

Compounds for the treatment of BRAF-associated diseases and disorders

Patents Applicationslast 30 patents

KRAS G12D INHIBITORS

KRAS G12D INHIBITORS

KRAS G12D INHIBITORS

KRAS G12D INHIBITORS

COMPOUNDS FOR THE TREATMENT OF BRAF-ASSOCIATED DISEASES AND DISORDERS

COMPOUNDS FOR THE TREATMENT OF BRAF-ASSOCIATED DISEASES AND DISORDERS

FUSED HETEROCYCLIC COMPOUNDS AS RET KINASE INHIBITORS

COMPOUNDS FOR THE TREATMENT OF BRAF-ASSOCIATED DISEASES AND DISORDERS

SUBSTITUTED PYRAZOLYL[4,3-C]PYRIDINE COMPOUNDS AS RET KINASE INHIBI...